NCT02178475 2018-07-23Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk ChemotherapyAmgenCompleted943 enrolled 28 charts
NCT01813721 2017-03-15Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.AmgenCompleted1,007 enrolled 9 charts